Download PDF
Thromb Haemost 1997; 77(02): 405
DOI: 10.1055/s-0038-1655978
Letter to the Editor
Schattauer GmbH Stuttgart

Impact of Factor V Leiden Mutation on Duration of Anticoagulation after a Single Thromboembolic Event

Claudia Rintelen
Medical Clinic I, Division of Haematology and Haemostaseology, Vienna, Austria
,
Ingrid Pabinger
Medical Clinic I, Division of Haematology and Haemostaseology, Vienna, Austria
,
Klaus Lechner
Medical Clinic I, Division of Haematology and Haemostaseology, Vienna, Austria
,
Christine Mann-halter
1   Department of Laboratory Medicine, Division of Molecular Biology, University Hospital Vienna, Vienna, Austria
› Author Affiliations
Further Information

Publication History

Received 13 September 1996

Accepted 13 September 1996

Publication Date:
10 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Ridker PM. Leiden and recurrent venous thromboembolism. Thromb Haemos 1996; 76: 815-816
    PubMedGoogle Scholar
  • 2 Rintelen C, Pabinger I, Knöbl P, Lechner K, Mannhalter C. Probability of recurrence of thrombosis in patients with and without factor V Leiden. Thromb Haemost 1996; 75: 229-232
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Ridker PM, Miletich J, Goldhaber SZ, Stampfer MJ, Lindpaintner K, Hennekens CH. Factor V Leiden and risks of recurrent idiopathic venous thromboemblism. Circulation 1995; 92: 2800-2802
    CrossrefPubMedGoogle Scholar
  • 4 Eichinger S, Pabinger I, Stüpflen A, Hirschl L, Bialonczyk C, Forberg E, Schneider B, Rintelen C, Lechner K, Kyrle PA. The risk of recurrent venous thrombosis after discontinuation of oral anticoagulants in patients without and with factor V Leiden and the predictive value of a molecular marker of thrombosis. Blood 1995; 86 (Suppl. 01) 615a
    PubMedGoogle Scholar